Lorelei Mucci, ScD, MPH
About Lorelei Mucci, ScD, MPH
Dr. Mucci earned a BS in Biology at Tufts University, an MPH in Epidemiology from Boston University, and an ScD in Epidemiology from the Harvard School of Public Health. She is currently an Assistant Professor in Medicine and Epidemiology at The Channing Laboratory, Brigham and Women’s Hospital.
A recent finding in prostate cancer biology is the existence of specific fusions of chromosomes in disparate regions of a patient’s genome. These fusions give rise to expression of molecules with strong cancer-causing properties. Emerging data suggest men with tumors that lack the fusion have an improved prognosis compared to men with fusion-positive prostate cancer. This scientist will study 1,500 prostate cancer patients to understand the relationship of the gene fusions to hormonal balance, energy balance, and healthy weight. The impact of these physiological properties on patient survival will be determined.
Dr. Mucci will be co-mentored by Philip Kantoff, MD (Dana-Farber Cancer Institute) and Meir Stampfer, MD, MPH (Harvard School of Public Health). Drs. Kantoff and Stampfer are among the most frequently cited prostate cancer researchers in the world for high-impact contributions.
Harvard School of Public Health – Boston, MA